Gracell Biotechnologies Inc. American Depositary Shares
GRCL
GRCL was delisted on the 21st of February, 2024.
35 hedge funds and large institutions have $203M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 9 closing their positions.
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
3% more funds holding
Funds holding: 34 → 35 (+1)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
55% less capital invested
Capital invested by funds: $450M → $203M (-$247M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
+$7.72M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$6.67M |
| 3 |
CII
Capital International Inc
Los Angeles,
California
|
+$5.67M |
| 4 |
SG Americas Securities
New York
|
+$2.07M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$8.33M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.42M |
| 3 |
Morgan Stanley
New York
|
-$3.43M |
| 4 |
BlackRock
New York
|
-$1.48M |
| 5 |
CCM
CloudAlpha Capital Management
Hong Kong
|
-$1.04M |
GRCL Hedge Fund Activity: Q4 2021 in Review
35 institutional investors reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q4 2021, worth a combined $203M — down 55% from $450M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GRCL positions and 9 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.
The largest buyer was Frazier Management, adding an estimated $7.72M. The largest seller was Viking Global Investors, cutting an estimated $8.33M.
- 35 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q4 2021, up from 34 in Q3 2021.
- Funds reported $203M of Gracell Biotechnologies Inc. American Depositary Shares stock for Q4 2021, down 55% quarter-over-quarter.
- 11 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q4 2021 and 9 closed out, a net change of +2 holders.
- The largest Gracell Biotechnologies Inc. American Depositary Shares buyer in Q4 2021 was Frazier Management, an estimated $7.72M added.
- The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q4 2021 was Viking Global Investors, an estimated $8.33M sold.
Based on aggregated 13F filings for Q4 2021.